Novel molecular targets in hepatic stellate cells for the treatment of liver fibrosis by Smith Cortínez, Natalia
 
 
 University of Groningen
Novel molecular targets in hepatic stellate cells for the treatment of liver fibrosis
Smith Cortínez, Natalia
DOI:
10.33612/diss.128130988
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2020
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Smith Cortínez, N. (2020). Novel molecular targets in hepatic stellate cells for the treatment of liver fibrosis.
University of Groningen. https://doi.org/10.33612/diss.128130988
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 26-12-2020
Propositions 
That belong to this PhD thesis 
Novel molecular targets to prevent hepatic stellate 
cells activation for the treatment of liver fibrosis 
 
1. Translation from basic research to clinical practice should be the driving force of pre-clinical 
research 
2. Targeting mitochondrial activity by repurposing clinically used drugs inhibits activation of 
hepatic stellate cells and thus could be short route to treat liver fibrosis - this thesis 
3. ER-to-Mitochondria calcium signaling in hepatic stellate cells is a novel target for the 
treatment of liver fibrosis - this thesis 
4. Vitamin C supplementation is needed when studying human hepatic stellate cells in vitro  - 
this thesis  
5. Clinically available hydroxylase inhibitors are potent drugs for the treatment of liver fibrosis, 
especially in combination with vitamin C - this thesis 
6. P4-ATPAses mediate collagen-I secretion and are novel therapeutic targets for the 
treatment of liver fibrosis - this thesis 
7. Choosing the correct models for obtaining clinically relevant data is important for patient-
care and for optimizing resources  
8. We need multi-targeted therapeutic approaches for treating liver fibrosis  
9. Researchers should actively communicate science to help the general population 
understand the relevance of their work for humanity 
10. We need the presence of others in our lives to endure hard times, not only in times of social 
distancing.  
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